Abstracts tagged "integrated safety"

Abstract Number: 1698 • ACR Convergence 2021

Integrated Safety Analysis Update for Filgotinib in Patients with Moderately to Severely Active Rheumatoid Arthritis Receiving Treatment over a Median of 2.2 Years

Kevin Winthrop¹, Yoshiya Tanaka², Tsutomu Takeuchi³, Alan Kivitz⁴, Mark Genovese⁵, Alena Pechonkina⁶, Franziska Matzkies⁶, Beatrix Bartok⁷, Kun Chen⁶, Deyuan Jiang⁶, Iyabode Tiamiyu⁶, Robin Besuyen⁸, Sander Strengholt⁹, Gerd Burmester¹⁰ and Jacques-Eric Gottenberg¹¹, ¹Oregon Health & Science University, Portland, OR, ²University of Occupational and Environmental Health, Kitakyushu, Japan, ³Div. Rheumatology, Keio University, Tokyo, Japan, ⁴Altoona Center for Clinical Research, Duncansville, PA, ⁵Gilead Sciences, Inc., Sunnyvale, CA, ⁶Gilead Sciences, Inc., Foster City, CA, ⁷Gilead Sciences, Inc., La Jolla, CA, ⁸Galapagos BV, Leiden, Netherlands, ⁹Galapagos, BV, New York, NY, ¹⁰Charité University Medicine Berlin, Berlin, Germany, ¹¹National Reference Center for Rare East South-West Autoimmune Systemic Diseases RESO, Strasbourg University Hospitals, Strasbourg, France